Stock Comparison
ABBV vs NVS
AbbVie Inc and Novartis AG ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$287.36B
P/E (TTM)
70.3
22.9
Forward P/E
17.7
16.9
Price/Sales
6.8
5.1
Price/Book
51.1
6.9
EV/EBITDA
25.8
14.5
Dividend Yield
2.03%
3.15%
Profitability
Net Margin
9.82%
24.14%
Operating Margin
29.77%
30.54%
Return on Equity
62.30%
30.30%
Return on Assets
10.50%
10.20%
Growth (YoY)
Revenue Growth
10.20%
0.80%
Earnings Growth
290.40%
-17.00%
Price & Risk
Beta
0.3
0.5
52-Week High
$263.65
$163.61
52-Week Low
$197.38
$118.18
Analyst Target
$274.36
$155.37
Compare ABBV and NVS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.